km.idaeo.ai · IDAEO 知識庫

🏛 本文属于主题馆「reports」 →

种植牙会后悔吗？网友的惨痛经历是真的吗？｜證據鏈

km 編輯部2026-08-13阅读约 41 分钟
#證據鏈#牙醫KM#台灣#植牙

本頁是〈种植牙会后悔吗？网友的惨痛经历是真的吗？〉的事實單元帳：每一條主張對應的來源、證據等級、地域與期間、原文引句與限制，逐條攤開。

种植牙会后悔吗？网友的惨痛经历是真的吗？｜證據鏈

F-Units（事实单元账）

  • F1｜confidence: verified｜basis: peer_reviewed（PMID 40523497）｜period: 2025 年发布，依据 2017 World Workshop 标准｜geo: universal｜span: 「The weighted mean prevalence of peri-implant mucositis was 63.0 % (CI: 57.6-68.2 %) at the patient level and 59.2 % (CI: 55.8-62.4 %) at the implant level」「Peri-implantitis was observed in 25.0 % (CI: 21.1-29.3 %) of patients and 18.0 % (CI: 15.8-20.5 %) of implants」「In non-smokers, the implant-level prevalence of peri-implant mucositis and peri-implantitis was 38.2 % (CI: 33.4-43.2 %) and 5.2 % (CI: 3.6-7.5 %), respectively」「The risk of bias was high in 50 %, moderate in 45 %」「The findings highlight the high worldwide prevalence of peri-implant diseases, emphasizing the need for uniform diagnostic protocols」｜caveat: 纳入 20 篇横断面研究，高偏倚风险者占一半；人群患病率不是个人风险。
  • F2｜confidence: verified｜basis: peer_reviewed（PMID 36261829）｜period: 检索 2005-01 至 2021-12，2022 年发布｜geo: universal｜span: 「Prevalence of peri-implantitis was 19.53% (95% CI 12.87-26.19) at the patient-level, and 12.53% (95% CI 11.67-13.39) at the implant-level and it remains highly variable even following restriction to the clinical case definition」「estimates of its prevalence fluctuate very much. This may be due to the wide variety of disease definitions」｜caveat: 纳入 57 篇研究；作者明确指出定义差异造成变异。
  • F3｜confidence: verified｜basis: clinical_guideline（PMID 25626479，第 11 届欧洲牙周病学工作坊共识报告）｜period: 2015 年发布｜geo: universal｜span: 「The management of peri-implant mucositis is considered as a preventive measure for the onset of peri-implantitis」「meta-analysis estimated a weighted mean prevalence for peri-implant mucositis of 43% (CI: 32-54%) and for peri-implantitis of 22% (CI: 14-30%)」「lack of regular supportive therapy in patients with peri-implant mucositis was associated with increased risk for onset of peri-implantitis」「whereas plaque accumulation has been established as aetiological factor, smoking was identified as modifiable patient-related and excess cement as local risk indicator」「patient-administered mechanical plaque control (with manual or powered toothbrushes) has been shown to be an effective preventive measure」「implant placement and prosthetic reconstructions need to allow proper personal cleaning, diagnosis by probing and professional plaque removal」｜caveat: 共识报告；建议层级不是个别处置指示。
  • F4｜confidence: verified｜basis: peer_reviewed（PMID 30904559）｜period: 检索 1997 至 2018-01，2019 年发布｜geo: universal｜span: 「The summary estimate for 10-year survival at the implant level was 96.4% (95% CI 95.2%-97.5%)」「The sensitivity meta-analysis summary estimate of survival was 93.2% (95% CI 90.1% to 95.8%)」「demonstrated a possible doubling of the risk of implant loss in the older age groups」｜caveat: 18 篇前瞻性观察研究；存留率指种植体仍在口内，不是“无并发症”。
  • F5｜confidence: verified｜basis: peer_reviewed（PMID 39305362）｜period: 2024 年发布｜geo: universal｜span: 「Three prospective studies (n = 237 implants) revealed a mean implant survival rate of 92% (95% CI: 82% to 97%), decreasing to 78% (95% CI: 74%-82%) after imputation」「A total of five retrospective studies (n = 1440 implants) showed a survival rate of 88% (95% CI: 78%-94%)」「follow-up is essential and shouldn't end after insertion or even after 10 years」｜caveat: 样本量小（前瞻性研究 237 支）；限粗糙表面螺旋形钛种植体；插补前后差异反映失访处理，不可只引用其一。
  • F6｜confidence: verified｜basis: peer_reviewed（PMID 39466662）｜period: 检索至 2024-04，2025 年发布｜geo: universal｜span: 「HP patients had a significantly greater risk for implant loss (HR: 1.75; 95% CI: 1.28-2.40; p = 0.0005」「and peri-implantitis (3.24; 95% CI: 1.58-6.64; p = 0.001」「a history of periodontitis has been proved to significantly increase the risk for implant loss, particularly at long follow-up」｜caveat: 14 篇前瞻性队列；作者注明病例定义和评估方法存在异质性。
  • F7｜confidence: verified｜basis: peer_reviewed（PMID 23062125）｜period: 平均随访 ≥5 年，2012 年发布｜geo: universal｜span: 「Only 66.4% of the patients were free of any complications after 5 years」「fractures of the veneering material (13.5%), peri-implantitis and soft tissue complications (8.5%), loss of access hole restoration (5.4%), abutment or screw loosening (5.3%), and loss of retention of cemented FDPs (4.7%)」「biological and technical complications were frequent (33.6%)」｜caveat: 限种植体支持固定牙桥；2012 年文献，材料代际已变化。
  • F8｜confidence: verified｜basis: peer_reviewed（PMID 23062124）｜period: 平均随访 ≥5 年，2012 年发布｜geo: universal｜span: 「survival of implants supporting SCs at 5 years amounted to 97.2% (95% CI: 96.3-97.9%), and at 10 years amounted to 95.2% (95% CI: 91.8-97.2%)」「The survival of implant-supported SCs was 96.3% (95% CI: 94.2-97.6%) after 5 years and 89.4% (95% CI: 82.8-93.6%) after 10 years」「a cumulative incidence of 8.8% (95% CI: 5.1-15.0%) for screw-loosening, 4.1% (95% CI: 2.2-7.5%) for loss of retention, and 3.5% (95% CI: 2.4-5.2%) for fracture of the veneering material after 5 years」「The cumulative 5-year aesthetic complication rate amounted to 7.1% (95% CI: 3.6-13.6%)」｜caveat: 限单颗种植体牙冠；种植体存留和牙冠存留是两个指标。
  • F9｜confidence: verified｜basis: peer_reviewed（PMID 30109300）｜period: 2018 年发布，纳入 16 篇｜geo: universal｜span: 「Patients had high expectations, with function followed by aesthetics being the most important expected improvements」「Costs were a major factor against implant-based therapy」「The expectations that implants will last a lifetime and require no special needs of oral hygiene were of concern」「Prior to treatment, patients have high expectations of implant therapy. In general, these expectations are met」｜caveat: 研究设计异质，作者指出可比性受限。
  • F10｜confidence: verified｜basis: peer_reviewed（PMID 40192114）｜period: 2025 年发布｜geo: universal｜span: 「The incidence of neurosensory alterations in patients with implants placed at a distance ≥ 2 mm from the mandibular canal was 0%」「for implants placed at a distance of 0-1 mm from the mandibular canal, the incidence of neurosensory alterations was 68%」「patients with implants that intruded into the canal had an incidence of 53% in the development of neurosensorial alterations」「Clinicians should be aware of the potential risk of nerve injury and adopt appropriate precautions, including meticulous preoperative planning and three-dimensional radiographic images」｜caveat: 0% 是该研究特定分层下的观察值，不等于该距离下不会发生；解读须连同分层条件和样本规模。
  • F11｜confidence: verified（同 #28 卡 F15 锚）｜basis: peer_reviewed（PMID 34074573）｜period: 1997 至 2013 全国登记，2022 年发布｜geo: universal｜span: 「other implant-related complications (infection, implant malposition, lack of bone at implant site, mechanical damage, or failed osseointegration)」｜caveat: 芬兰理赔登记；仅用于“神经损伤属于已知并发症类别”。
  • F12｜confidence: verified｜basis: peer_reviewed（PMID 39286589）｜period: 纳入 2007 至 2020 年文献，2024 年发布｜geo: universal｜span: 「The selected studies highlighted several aesthetic issues, such as recession, marginal bone loss, gingival loss, and pink aesthetic scores related to dental implants placed in the aesthetic zone」「Addressing these challenges necessitates meticulous treatment planning, effective soft tissue management, regular follow-ups, patient education, expectation management, and collaborative efforts among specialists」｜caveat: 纳入 14 篇、时间窗口较窄；作者承认外推性有限。
  • F13｜confidence: verified｜basis: peer_reviewed（PMID 25358599）｜period: 2014 年发布｜geo: universal｜span: 「Most studies are cross sectional in nature and the quality of reporting varies considerably」「Expectations with respect to aesthetics and function are key attributes considered」｜caveat: 叙述性综述，无法进行荟萃分析。
  • F14｜confidence: verified｜basis: peer_reviewed（PMID 26701350）｜period: 检索至 2015-06，2016 年发布｜geo: universal｜span: 「implant therapy must not be limited to the placement and restoration of dental implants but to the implementation of PIMT」「our findings suggest reason to claim a minimum recall PIMT interval of 5 to 6 mo」「even in the establishment of PIMT, biologic complications might occur」｜caveat: 作者明确说明必须按个人风险轮廓调整；不是固定处方。
  • F15｜confidence: verified｜basis: peer_reviewed（PMID 39393606）｜period: 检索至 2024-06，2024 年发布｜geo: universal｜span: 「At implant level, a meta-analysis of 21 included cohort studies showed that smoking was associated with increased risk of early dental implant failure compared with non-smoking (odds ratio [OR], 2.59; 95 % confidence interval [CI], 2.08-3.23)」「with a total of 59,246 implants at implant level and 14,115 patients at individual level」｜caveat: 观察性研究合并，不作因果推论；比值比 2.59 来自 32 篇中的 21 篇队列研究、种植体层级，不要与个人层级比值比 2.00 混用。
  • F16｜confidence: verified（2026-08-06 以 ego-browser 实载逐字比对；同 VERIFIED-FACTS.md 锚）｜basis: law｜period: 现行条文｜geo: TW｜span: 《全民健康保險法》第 51 條「十一、義齒、義眼、眼鏡、助聽器、輪椅、拐杖及其他非具積極治療性之裝具。」｜caveat: 个别项目给付以健保署现行公告为准，本卡不作给付判断。
  • F17｜confidence: verified（同 #28 卡 F8 锚）｜basis: peer_reviewed（PMID 35056347）｜period: 2021 年发布，纳入 292 篇｜geo: universal｜span: 「implants in smokers had a higher failure risk in comparison with non-smokers (OR 2.402, p < 0.001)」｜caveat: 观察性证据合并，不作因果推论。
  • F18｜confidence: verified（2026-08-06 以 ego-browser 实载，页面逐字显示提供机关）｜basis: official_statement｜period: 数据集现况（诠释资料更新时间 2026-07-13）｜geo: TW｜span: 政府資料開放平臺資料集「臺北市醫療收費標準」，提供機關「臺北市政府衛生局」｜caveat: 单一县市例证，其他县市页面在放量前须逐一补验；另据 VERIFIED-FACTS.md（2026-08-05 OP 以 ego-browser 逐项实测），健保署“醫材比價網”两条品项类别均不含牙科，牙科自费项目不得以该网站作为核查渠道；本卡核查陷阱段据此。
  • F19｜confidence: verified｜basis: peer_reviewed（PMID 23543525，Cochrane 系统综述）｜period: 检索至 2012-06，2013 年发布｜geo: universal｜span: 「dental implants are kept load-free for 3 to 8 months to establish osseointegration (conventional loading)」「immediate (within 1 week), early (between 1 week and 2 months), and conventional (after 2 months) loading of osseointegrated implants」「the mean rate of implant failure in all 26 trials was a low 2.5%」「having a follow-up of 4 months to 1 year」｜caveat: 2.5% 是纳入试验随访 4 个月至 1 年的短期数字，不能与 10 年、20 年数字互换；负载时机属于临床判断。
  • F20｜confidence: verified（2026-08-06 以 ego-browser 实载逐字比对）｜basis: law｜period: 现行条文｜geo: TW｜span: 《醫療法》第 63 條「醫療機構實施手術，應向病人或其法定代理人、配偶、親屬或關係人說明手術原因、手術成功率或可能發生之併發症及危險，並經其同意，簽具手術同意書及麻醉同意書，始得為之。」｜caveat: 条文引述，不是法律意见。
  • F21｜confidence: verified（2026-08-06 以 ego-browser 实载逐字比对）｜basis: law｜period: 现行条文｜geo: TW｜span: 《醫療法》第 81 條「醫療機構診治病人時，應向病人或其法定代理人、配偶、親屬或關係人告知其病情、治療方針、處置、用藥、預後情形及可能之不良反應。」｜caveat: 条文引述，不是法律意见。
  • F22｜confidence: verified（同 #28 卡 F10 锚）｜basis: peer_reviewed（PMID 36807599）｜period: 检索至 2022-08，2023 年发布｜geo: universal｜span: 「diabetic patients with dental implants and good glycaemic control have a significantly lower risk of peri-implantitis (odds ratio [OR] = 0.16」「risk of dental implant failure (OR = 3.76; 95% CI: 1.50-9.45; I2 : 0%) appears to be greater under irregular or no SPC」｜caveat: 间接证据；作者标注证据局限。
  • F23｜confidence: verified｜basis: peer_reviewed（PMID 30328195）｜period: 随访 ≥3 年的研究，2018 年发布｜geo: universal｜span: 「Therapy of peri-implantitis followed by regular supportive care resulted in high patient- and implant-level survival in the medium to long term」「Favourable results were reported, with clinical improvements and stable peri-implant bone levels in the majority of patients」｜caveat: 研究设计和病例定义异质；作者指出报告质量影响资料提取。
  • F24｜confidence: 结构性整理（编辑框架，非外部事实宣称）｜basis: editorial_framework｜period: 2026-08-06｜geo: universal｜span: “不引用也不否定网络论坛贴文”的处理原则、将常见抱怨对应至文献并发症类别的五类分流框架、“存留率须连同随访年限和人群一起看”的阅读规则、费用问法与核查陷阱提示（牙科不在健保署醫材比價網品项范围，见 VERIFIED-FACTS.md 2026-08-05 实测）｜caveat: 编辑性沟通框架，不是诊断工具，不替代临床判断。
  • F25｜confidence: verified｜basis: peer_reviewed（PMID 37339881）｜period: 检索至 2022-07-21，2023 年发布｜geo: universal｜span: 「Provision of SPIC following peri-implantitis therapy may prevent disease recurrence or progression」「with recall intervals varying between 2 months and annually」「Insufficient evidence is available to identify (i) a specific supportive care protocol for secondary prevention of peri-implantitis」｜caveat: 纳入 15 篇，异质性高，未进行荟萃分析。
  • F26｜confidence: verified｜basis: peer_reviewed（PMID 27183062）｜period: 检索至 2014-11，2016 年发布｜geo: universal｜span: 「The survival rate for implant replacement at the second attempt was 88.84% (390/439; range, 71% to 94.6%)」「Thirty-one implants were replaced for a third attempt with a mean survival rate of 74.19% (23/31)」「Implant replacement is a reasonably feasible option for scenarios of early and late implant failure. However, modifiable risk factors must be controlled before proceeding for implant replacement」｜caveat: 仅 7 篇（5 个回顾性队列加 2 个病例系列）；第三次植入样本 31 支，区间宽。
  • F27｜confidence: verified｜basis: internal_dataset｜period: 2025-03 至 2026-08 GSC｜geo: TW｜span: backlog #7“植牙後悔”“植牙慘痛經驗ptt”等 11 个词项合计曝光 270,300，跨 共 6 个网站｜caveat: 曝光为资产级数字，不是去重流量；发布转换时本条不输出（08-05 裁定：内部数据不进入可见层）。
  • F28｜confidence: verified（2026-08-06 以 ego-browser 实载逐字比对）｜basis: law｜period: 现行条文｜geo: TW｜span: 《醫療法》第 87 條「廣告內容暗示或影射醫療業務者，視為醫療廣告。醫學新知或研究報告之發表、病人衛生教育、學術性刊物，未涉及招徠醫療業務者，不視為醫療廣告。」｜caveat: 条文引述，不是法律意见。

来源清单

取用日期均为 2026-08-06；PubMed 条目以 E-utilities efetch 取得摘要原文并逐条逐字比对，台湾法规与官方资料以 ego-browser 实载页面逐字比对。

  1. Reis INRD, et al. The prevalence of peri-implant mucositis and peri-implantitis based on the world workshop criteria: A systematic review and meta-analysis. J Dent. 2025;160:105914. PMID 40523497
  2. Diaz P, et al. What is the prevalence of peri-implantitis? A systematic review and meta-analysis. BMC Oral Health. 2022;22(1):449. PMID 36261829
  3. Jepsen S, et al. Primary prevention of peri-implantitis: managing peri-implant mucositis. J Clin Periodontol. 2015;42 Suppl 16:S152-7. PMID 25626479
  4. Howe MS, Keys W, Richards D. Long-term (10-year) dental implant survival: A systematic review and sensitivity meta-analysis. J Dent. 2019;84:9-21. PMID 30904559
  5. Kupka JR, et al. How far can we go? A 20-year meta-analysis of dental implant survival rates. Clin Oral Investig. 2024;28(10):541. PMID 39305362
  6. Annunziata M, et al. Effectiveness of Implant Therapy in Patients With and Without a History of Periodontitis: A Systematic Review With Meta-Analysis of Prospective Cohort Studies. J Periodontal Res. 2025;60(6):524-543. PMID 39466662
  7. Pjetursson BE, et al. A systematic review of the survival and complication rates of implant-supported fixed dental prostheses (FDPs) after a mean observation period of at least 5 years. Clin Oral Implants Res. 2012;23 Suppl 6:22-38. PMID 23062125
  8. Jung RE, et al. Systematic review of the survival rate and the incidence of biological, technical, and aesthetic complications of single crowns on implants reported in longitudinal studies with a mean follow-up of 5 years. Clin Oral Implants Res. 2012;23 Suppl 6:2-21. PMID 23062124
  9. Korfage A, et al. Patients' expectations of oral implants: a systematic review. Eur J Oral Implantol. 2018;11 Suppl 1:S65-S76. PMID 30109300
  10. Peña-Cardelles JF, et al. Inferior alveolar nerve damage related to dental implant placement. A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2025;30(4):e578-e589. PMID 40192114
  11. Pääsky E, et al. Are women more susceptible than men to iatrogenic inferior alveolar nerve injury in dental implant surgery? Int J Oral Maxillofac Surg. 2022;51(2):251-256. PMID 34074573
  12. Alanazi S. Aesthetic problems related to dental implants in the aesthetic zone: A systematic review. Saudi Dent J. 2024;36(9):1179-1183. PMID 39286589
  13. Yao J, et al. Patients' expectations to dental implant: a systematic review of the literature. Health Qual Life Outcomes. 2014;12:153. PMID 25358599
  14. Monje A, et al. Impact of Maintenance Therapy for the Prevention of Peri-implant Diseases: A Systematic Review and Meta-analysis. J Dent Res. 2016;95(4):372-9. PMID 26701350
  15. Fan YY, et al. Smoking in relation to early dental implant failure: A systematic review and meta-analysis. J Dent. 2024;151:105396. PMID 39393606
  16. 全民健康保險法 第 51 條（全国法规资料库）
  17. Mustapha AD, et al. Smoking and Dental Implants: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2021;58(1):39. PMID 35056347
  18. 政府資料開放平臺：臺北市醫療收費標準（提供機關：臺北市政府衛生局）
  19. Esposito M, et al. Interventions for replacing missing teeth: different times for loading dental implants. Cochrane Database Syst Rev. 2013;(3):CD003878. PMID 23543525
  20. 台湾《医疗法》第 63 条（全国法规资料库）
  21. 台湾《医疗法》第 81 条（全国法规资料库）
  22. Carra MC, et al. Primordial and primary prevention of peri-implant diseases: A systematic review and meta-analysis. J Clin Periodontol. 2023;50 Suppl 26:77-112. PMID 36807599
  23. Roccuzzo M, et al. Clinical outcomes of peri-implantitis treatment and supportive care: A systematic review. Clin Oral Implants Res. 2018;29 Suppl 16:331-350. PMID 30328195
  24. 编辑框架：本站“不引用也不否定论坛贴文”原则及五类对应结构（无外部来源，标为结构性整理）
  25. Stiesch M, et al. Supportive care for the prevention of disease recurrence/progression following peri-implantitis treatment: A systematic review. J Clin Periodontol. 2023;50 Suppl 26:113-134. PMID 37339881
  26. Zhou W, et al. Feasibility of Dental Implant Replacement in Failed Sites: A Systematic Review. Int J Oral Maxillofac Implants. 2016;31(3):535-45. PMID 27183062
  27. 内部数据：`analysis/reports/km-dental-backlog.md` #7 附录（词×站×曝光可逐笔对账）
  28. 台湾《医疗法》第 87 条（全国法规资料库）

内部引用链

  • 并发症同族（植骨端的后遗症、失败与警示征象）：植骨粉会有后遗症吗？失败了会怎样？（KM-DENTAL-28）
  • 费用期待同族（报价单由哪四部分组成、如何比较才不会比较错）：种植牙一颗到底多少钱？（KM-DENTAL-09）
  • 术后照护同族（种植牙后多久能吃东西、咖啡和茶）：种植牙后多久能吃东西？（KM-DENTAL-20）
发布闸门提醒：本卡为 draft。zh-Hans／en／ja 未齐前不得进入 km_entries；F27 内部数据和 frontmatter 曝光栏位在发布转换时剥除，不进入可见层。

FAQ

网络上那些“植牙惨痛经验”是真的吗？
**无法逐条核实，本卡不引用也不否定 [F24]。** 但贴文抱怨的类别在文献中都有对应：种植体周围疾病 [F1][F2][F3]、种植体失败 [F4][F5]、神经感觉异常 [F10][F11]、修复端并发症 [F7][F8][F12]、期待落差 [F9]。与其判断贴文真假，不如把这五类逐项带进诊间问。
ネットの「インプラントのつらい体験談」は本当ですか？ — **一件ずつ検証できないため、本カードは引用も否定もしません [F24]。** ただし不満の型には、インプラント周囲疾患 [F1][F2][F3]、インプラント失敗 [F4][F5]、神経感覚異常 [F10][F11]、補綴物合併症 [F7][F8][F12]、期待のずれ [F9] という文献上の対応があります。投稿の真偽を決めるより、この五つを診察室で順に尋ねてください。
Are those online “dental implant horror stories” real? — **They cannot be verified one by one; this card neither cites nor dismisses them [F24].** The kinds of complaints do, however, correspond to categories in the literature: peri-implant diseases [F1][F2][F3], implant failure [F4][F5], neurosensory alterations [F10][F11], prosthetic complications [F7][F8][F12], and expectation gaps [F9]. Rather than decide whether a post is true, take these five categories into the consultation one at a time.
种植牙能用一辈子吗？
**现有文献只提供带有随访年限的存留率，没有“用一辈子”这样的结论。** 关于患者期待的系统综述直接把“种植体可以用一辈子”和“不需要特别口腔卫生照护”列为值得关注的期待 [F9]。可核查的数字都有随访年限：10 年种植体层级为 96.4%，敏感性分析为 93.2% [F4]；20 年前瞻性研究为 92%，插补后为 78%，回顾性研究为 88% [F5]；假牙端 5 年并发症合计为 33.6% [F7]。这些是人群层级数字，不能推估个人结果。
インプラントは一生使えますか？ — **現行文献が示すのは追跡期間つきの生存率であり、「一生使える」という結論ではありません。** 患者の期待のシステマティックレビューは、「インプラントは一生もつ」「特別な口腔衛生ケアは不要」を懸念すべき期待として直接挙げています [F9]。確認できるのは追跡期間つき生存率です。10 年のインプラントレベルで 96.4%、感度分析で 93.2% [F4]、20 年の前向き研究で 92%、補完後 78%、後ろ向き研究で 88% [F5] でした。補綴物側の 5 年合計合併症は 33.6% でした [F7]。これらは集団レベルの数値で、個人の結果は予測できません。
Can an implant last a lifetime? — **Available literature provides survival figures with follow-up periods, not a conclusion that an implant lasts “a lifetime.”** A systematic review of patient expectations explicitly identifies “implants will last a lifetime” and “no special oral-hygiene care is needed” as expectations of concern [F9]. Verifiable figures have follow-up periods: implant-level survival was 96.4% at 10 years and 93.2% in sensitivity analysis [F4]; prospective 20-year studies reported 92%, falling to 78% after imputation, while retrospective studies reported 88% [F5]. Prosthetic complications totalled 33.6% at 5 years [F7]. These are population-level figures and cannot predict an individual outcome.
种植牙失败后还能再做吗？
**文献记录的是人群层级的可行性，不是个人处置建议。** 在先前失败部位重新种植，第二次的存留率为 88.84%，第三次为 74.19%（仅 31 支）；该综述同时要求重新种植前先控制可改变的风险因素 [F26]。种植体周围炎方面，一份系统综述记录了治疗后接受规律支持性照护者中长期的存留结果偏正面，但同时写明病例定义、治疗方式和人群差异明显，不能据此预测个人疗效 [F23]；支持性照护的具体方案，现有证据也仍不足以指定 [F25]。要不要重做、何时重做，应由牙医师评估。
インプラントが失敗したら、もう一度できますか？ — **文献が記録しているのは集団レベルの実行可能性であり、個人への処置提案ではありません。** 既に失敗した部位での再植立は、二回目の生存率 88.84%、三回目 74.19%（31 本のみ）で、同レビューは再植立前に変更可能なリスク因子を管理するよう求めています [F26]。インプラント周囲炎については、治療後に定期的な支持的ケアを受けた人の中長期の生存結果は良好な傾向でしたが、症例定義、治療、集団の差が大きく、個人の効果は予測できないとも記されています [F23]。支持的ケアの具体的な手順を指定できるほどの根拠もありません [F25]。再治療するか、いつするかは歯科医師の評価が必要です。
If an implant fails, can it be done again? — **The literature documents population-level feasibility, not treatment advice for an individual.** At previously failed sites, survival for the second attempt was 88.84% and for the third attempt 74.19% (only 31 implants); the review also requires modifiable risk factors to be controlled before reimplantation [F26]. For peri-implantitis, a systematic review reported favourable medium- to long-term survival findings after treatment followed by regular supportive care, but also described substantial differences in case definitions, treatments, and populations, so it cannot predict individual effectiveness [F23]. Available evidence also remains insufficient to specify a particular supportive-care protocol [F25]. Whether and when to repeat treatment requires assessment by a dentist.

来源锚定

引用本文

km 編輯部・《种植牙会后悔吗？网友的惨痛经历是真的吗？｜證據鏈》・IDAEO 知識庫・2026-08-13・https://km.idaeo.ai/post/reports/dental-implant-regret-evidence

相关文章

更新 2026-08-13T14:17:18.591Z · server-rendered · four-language · IDAEO 知識庫